Oncology Venture Sweden Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
M&A
Oncology Venture Sweden General Information
Description
Oncology Venture Sweden AB develops oncology products to improve the efficacy of the drugs and the response rate in cancer patients. The company's products in pipeline include APO010 and Irofulven.
Contact Information
Website
www.oncologyventure.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
- Venlighedsvej 1
- DK-2970 Horsholm
- Denmark
+45 21 00 00 00
Oncology Venture Sweden Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 24-Aug-2018 | 00.000 | Completed | Profitable | ||
| 3. IPO | 17-Sep-2015 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 2. Early Stage VC | 24-Feb-2015 | $944K | $1.46M | Completed | Generating Revenue | |
| 1. Seed Round | 19-Feb-2015 | $514K | $514K | Completed | Startup |
Oncology Venture Sweden Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Peter Jensen MD | Chief Executive Officer |
Oncology Venture Sweden Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
